Pulse Explorar nav.journalClub Debates Tendências Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

Ning Kang | Synapse

NK

Ning Kang

Renal cell carcinoma treatment

HEC Pharm (China)

About

Research focus

Renal cell carcinoma treatment

Impact

82 pubs · 1,101 cites · h-index 19

Affiliations

Work Experience

HEC Pharm (China)

2026 - Present

Sun Yat-sen University

2021 - 2025

Fudan University

2025 - 2025

Zhongshan Hospital

2025 - 2025

The First Affiliated Hospital, Sun Yat-sen University

2025 - 2025

Publications